Political Quotes

“in recent months, the high cost of pharmaceutical products has been front and center in national news, sometimes with astonishing examples like the unconscionable price-hike by Turing Pharmaceuticals of their drug for patients with HIV from $13.50 to $750 per pill overnight. Pharmaceutical companies should be compensated for their important work developing life-saving treatments, but when companies engage in predatory practices at the expense of consumers, we must act. That is why today, I am introducing the Creating and Restoring Equal Access to Equivalent Samples, CREATES, Act, bipartisan legislation to end inappropriate delay tactics that are used by some brand-name drug manufacturers to block competition from more affordable generic drugs. The first delay tactic addressed by the CREATES Act involves the withholding of drug samples that generic manufacturers need to gain regulatory approval. Federal law requires generic competitors to prove that their low-cost alternative is equally safe and effective as the brand-name drug with which they wish to compete. Unfortunately, some brand-name companies are preventing generic manufacturers from obtaining the samples they need to make the necessary comparison. This simple delay tactic uses regulatory safeguards as a weapon to block competition.…”